Close Menu
Home › About Us › Our Staff › Neil Versel

Neil Versel

Editor
Phone Number
+1-773-348-0046
Email
nversel@genomeweb.com
Neil Versel at Genomeweb / 360dx Neil Versel at Genomeweb / 360dx

Neil Versel is an editor at GenomeWeb. He covers the life science and healthcare informatics markets.

Articles Authored by Neil Versel

Jun 07, 2019

Online Platform Helping Adventist Health Improve Breast Cancer Risk Assessment

Premium

The California health system has expanded its partnership with CancerIQ to integrate risk assessment and oncology patient management into its EHR.

May 21, 2019

Q&A: Biden Cancer Initiative President Greg Simon Discusses Data Sharing in Precision Oncology

Premium
Greg Simon - Biden Cancer Initiative

Standards for interoperability and better cooperation among stakeholders will help unleash the power of genomics in cancer care, says the head of the Biden Cancer Initiative.

May 20, 2019

Newly Rebranded Inteliquet Bolstering Precision Oncology Offerings Through NCI Contract

Premium

The company formerly known as TransMed Systems looks to bring "clarity and transparency" to the emerging field of precision oncology and in patient-trial matching.

May 14, 2019

BostonGene Eyes Precision Oncology as it Emerges from Stealth

Premium

With $50 million from Japanese firm NEC, biomedical software startup BostonGene seeks to assess patients' "immune fitness" in the quest for better therapies.

May 02, 2019

Dutch Pediatric Cancer Center Builds Informatics Infrastructure From Scratch

Premium

The year-old Princess Máxima Center, based in Utrecht, has turned to bioinformatics firm The Hyve to address integration and interoperability issues.

Mar 25, 2019

Q&A: Roche Diagnostics' Okan Ekinci Discusses Data Science in Precision Medicine Era

Premium

Symbolized by its first time exhibiting at HIMSS, Roche Diagnostics is using data to bridge the worlds of imaging, sequencing, diagnostics, drug discovery, and treatment.

Feb 01, 2019

Precision Medicine Platform for Oncology Aims to Streamline Molecular Testing, Therapy Decision-Making

Premium

City of Hope and Texas Oncology are the first customers for Trapelo, a decision support platform from Innovation Insights that involves labs and payors.

Jan 30, 2019

iReceptor Plus Consortium Wants to Improve Immunological Data Sharing

Premium

The new multinational consortium, backed by the EU and Canada, seeks to improve understanding of immune responses and uncover new therapeutic targets.

Dec 03, 2018

Tempus Ramps Up AI-Driven Precision Oncology, Eyes Other Markets

Premium

After raising $320M in venture capital, Tempus hopes to sequence 100,000 samples in 2019 as it expands its precision medicine program into depression and diabetes.

May 31, 2018

PanDrugs System Aims to Advance Precision Cancer Care by Matching Treatments to Mutations

Premium

Informaticians at Spain's National Cancer Research Centre develop a methodology for evaluating likely drug efficacy based on specific patient genotypes.

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb LLC.  All Rights Reserved.